13F-HR filed by Sofinnova Investments, Inc.
Sofinnova Investments, Inc. filed this 13F-HR for the quarter ended 2021-06-30, filed 2021-08-16, with 67 holding rows worth $1,735,092,000.
- Accession
- 0001104659-21-106048
- Filer
- CIK 1631134
- Filed
- 2021-08-16
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2021
A holdings report, 67 entries on the cover page, a total value of $1,735,092,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,735,092,000 with VALUE read as thousands by filing date, 13F file number 028-18774. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| NATERA INC COM | 632307104 | Stock | 3,100,560 | $352,007,000 | thousands by filing date | |
| KARUNA THERAPEUTICS INC | 48576A100 | COM | 1,952,441 | $222,559,000 | thousands by filing date | |
| AEROVATE THERAPEUTICS INC | 008064107 | COM | 3,758,686 | $85,811,000 | thousands by filing date | |
| Y-mAbs Therapeutics Inc | 984241109 | Common Stock | 2,194,278 | $74,167,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 521,923 | $68,659,000 | thousands by filing date | |
| ASTRAZENECA PLC SPONSORED ADR | 046353108 | ADR | 959,632 | $57,482,000 | thousands by filing date | |
| ISHARES TR | 464287956 | ISHARES BIOTECH | 325,000 | $53,186,000 | thousands by filing date | put |
| BOLT BIOTHERAPEUTICS INC | 097702104 | COM | 2,754,437 | $42,584,000 | thousands by filing date | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 216,085 | $38,768,000 | thousands by filing date | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 2,914,776 | $38,650,000 | thousands by filing date | |
| BIOGEN INC COM | 09062X103 | Stock | 110,600 | $38,297,000 | thousands by filing date | |
| INOZYME PHARMA INC | 45790W108 | COM | 2,028,308 | $34,562,000 | thousands by filing date | |
| GALERA THERAPEUTICS EQUICLASS EQUITY | 36338D108 | COMMON STOCK | 3,083,712 | $30,313,000 | thousands by filing date | |
| ACCELERON PHARMA INC | 00434H108 | COM | 233,638 | $29,319,000 | thousands by filing date | |
| ALIGN TECHNOLOGY INC COM | 016255101 | Stock | 47,093 | $28,774,000 | thousands by filing date | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 581,940 | $24,599,000 | thousands by filing date | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 844,169 | $24,025,000 | thousands by filing date | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 298,500 | $23,205,000 | thousands by filing date | |
| ARK ETF TR | 00214Q952 | GENOMIC REV ETF | 250,000 | $23,125,000 | thousands by filing date | put |
| HERON THERAPEUTICS INC | 427746102 | COM | 1,467,675 | $22,778,000 | thousands by filing date | |
| CHECKMATE PHARMACEUTICALS IN | 162818108 | COM | 3,606,707 | $21,496,000 | thousands by filing date | |
| NEXTCURE INC | 65343E108 | COM | 2,671,856 | $21,455,000 | thousands by filing date | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 449,082 | $20,155,000 | thousands by filing date | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 203,200 | $19,775,000 | thousands by filing date | |
| EXELIXIS INC COM | 30161Q104 | Stock | 1,079,681 | $19,672,000 | thousands by filing date | |
| AKOUOS INC | 00973J101 | COM | 1,515,074 | $19,014,000 | thousands by filing date | |
| INSULET CORP COM | 45784P101 | Stock | 68,500 | $18,804,000 | thousands by filing date | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 88,214 | $17,787,000 | thousands by filing date | |
| REGENXBIO INC | 75901B107 | COM | 427,740 | $16,618,000 | thousands by filing date | |
| NUCANA PLC | 67022C106 | ADR | 5,599,999 | $15,512,000 | thousands by filing date | |
| AGENUS INC | 00847G705 | COM NEW | 2,769,900 | $15,207,000 | thousands by filing date | |
| DEXCOM INC COM | 252131107 | Stock | 33,713 | $14,395,000 | thousands by filing date | |
| ObsEva SA | H5861P103 | COM | 4,749,623 | $14,391,000 | thousands by filing date | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 313,159 | $12,783,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 78,538 | $12,686,000 | thousands by filing date | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 219,033 | $12,071,000 | thousands by filing date | |
| REATA PHARMACEUTICALS INC | 75615P103 | CL A | 79,601 | $11,266,000 | thousands by filing date | |
| UNIQURE NV | N90064101 | SHS | 324,303 | $9,989,000 | thousands by filing date | |
| Amgen Inc. | 031162100 | COM | 40,500 | $9,872,000 | thousands by filing date | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 481,323 | $9,525,000 | thousands by filing date | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 444,372 | $9,265,000 | thousands by filing date | |
| Nucana PLC | GB00BYWYV | COMMON SHARES | 2,400,000 | $6,648,000 | thousands by filing date | |
| MACROGENICS INC | 556099109 | COM | 234,504 | $6,299,000 | thousands by filing date | |
| CHEMOCENTRYX INC | 16383L106 | COM | 465,637 | $6,235,000 | thousands by filing date | |
| MARINUS PHARMACEUTICALS INC | 56854Q200 | COM NEW | 346,160 | $6,210,000 | thousands by filing date | |
| COHERUS ONCOLOGY INC | 19249H103 | COM | 434,555 | $6,010,000 | thousands by filing date | |
| CYTEIR THERAPEUTICS INC | 23284P103 | COMMON | 265,000 | $5,671,000 | thousands by filing date | |
| FIBROGEN INC | 31572Q958 | PUT | 200,000 | $5,326,000 | thousands by filing date | put |
| IMMATICS N.V | N44445109 | SHS | 443,370 | $5,148,000 | thousands by filing date | |
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 1,170,584 | $5,127,000 | thousands by filing date | |
| TCR2 THERAPEUTICS INC | 87808K106 | COM | 296,282 | $4,862,000 | thousands by filing date | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 134,724 | $4,505,000 | thousands by filing date | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 259,465 | $4,486,000 | thousands by filing date | |
| JOUNCE THERAPEUTICS INC | 481116101 | COM | 624,756 | $4,248,000 | thousands by filing date | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 46,386 | $4,026,000 | thousands by filing date | |
| ALIGOS THERAPEUTICS INC COM NEW | 01626L105 | Stock | 164,051 | $3,344,000 | thousands by filing date | |
| CHEMOCENTRYX INC | 16383L906 | CALL | 215,000 | $2,879,000 | thousands by filing date | call |
| OTONOMY INC | 68906L105 | COM | 1,251,256 | $2,790,000 | thousands by filing date | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 71,661 | $2,753,000 | thousands by filing date | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 158,609 | $2,508,000 | thousands by filing date | |
| ACADIA PHARMACEUTICALS INC | 004225908 | COM | 100,000 | $2,439,000 | thousands by filing date | call |
| TCR2 THERAPEUTICS INC | 87808K956 | PUT | 139,700 | $2,292,000 | thousands by filing date | put |
| SYNLOGIC INC | 87166L100 | COM | 574,972 | $2,237,000 | thousands by filing date | |
| SAVARA INC | 805111101 | COM | 1,278,424 | $2,173,000 | thousands by filing date | |
| PDS BIOTECHNOLOGY CORP | 70465T107 | COM | 142,635 | $1,790,000 | thousands by filing date | |
| CTI BIOPHARMA CORP | 12648L601 | COM | 171,619 | $429,000 | thousands by filing date | |
| SIERRA ONCOLOGY INC | 82640U404 | CMN | 2,500 | $49,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-21-106048 | this filing | 2021-08-16 | acceptance time not in the bulk data set |